JOSEPH P SLATTERY
CIK 1246530 · EVP and CFO · last filed 2026-06-18
JOSEPH P SLATTERY is an EVP and CFO who has filed 95 SEC Form 4 insider transactions across 8 companies since 2007. The most recent filing, for IMA, was dated Jun 18, 2026. Across all open-market trades the lifetime net is −$7.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $350.5K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$350.5K
8
95
-$7.39M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IMA | Director | 16,000 | $5.76 | $92.2K | $95.8K | 3 | 2026-06-18 |
| CVRX | Director | 39,365 | $4.95 | $194.9K | $71.7K | 14 | 2026-06-03 |
| REPL | Director | 11,867 | $5.35 | $63.5K | -$139.2K | 10 | 2026-04-07 |
| Morphic Holding, Inc. (MORF) Delisted | Director | 9,066 | $56.99 | $516.7K | $149.4K | 8 | 2024-06-05 |
| ASENSUS SURGICAL, INC. (TRXC) Delisted | EVP and CFO | 125,000 | $4.08 | $510.0K | -$7.95M | 28 | 2019-05-15 |
| BAXANO SURGICAL, INC. (BAXS) Delisted | Executive V.P. and CFO | 229,571 | — | — | $0 | 1 | 2013-06-04 |
| BAXANO SURGICAL, INC. (TSON) Delisted | Executive V.P. and CFO | 142,994 | — | — | $351.0K | 19 | 2013-03-01 |
| MICROMET, INC. (MITI) Delisted | Director | 0 | — | — | $24.8K | 7 | 2012-03-06 |
Recent Filings
95 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-18 | IMA | Grant (A) | — | $0 | EDGAR |
| 2026-06-03 | CVRX | Grant (A) | +8,720 | $0 | EDGAR |
| 2026-04-07 | REPL | Grant (A) | — | $0 | EDGAR |
| 2025-12-29 | IMA | Buy (P) | +16,000 | $95.8K | EDGAR |
| 2025-12-22 | IMA | Grant (A) | — | $0 | EDGAR |
| 2025-06-05 | CVRX | Grant (A) | — | $0 | EDGAR |
| 2025-04-03 | REPL | Grant (A) | — | $0 | EDGAR |
| 2024-08-20 | — | Disp (D) | −9,066 | $0 | |
| 2024-08-15 | CVRX | Buy (P) | +3,000 | $24.3K | EDGAR |
| 2024-08-08 | CVRX | Buy (P) | +3,000 | $24.7K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.